Local production of anti-CD4 antibody by transgenic allogeneic grafts affords partial protection

Transplantation

Volumn 70, Issue 6, 2000, Pages 947-954

  Zhan, Yifan ^a   Martin, Roland M ^a,b   Sutherland, Robyn M ^a   Brady, Jamie L ^a   Lew, Andrew M ^a,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b CSL LIMITED   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIBODY; IMMUNOMODULATING AGENT; MONOCLONAL ANTIBODY GK2C; OKT 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL INFILTRATION; FETUS; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0034721489     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200009270-00012     Document Type: Article

References (24)

1. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule
2. How do monoclonal antibodies induce tolerance? A role for infectious tolerance?
3. Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival
4. Improved survival of biolistically transfected mouse islet allografts expressing CTLA4-Ig or soluble Fas ligand
5. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig
6. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model
7. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts
8. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice
9. DNA immunization: Induction of higher avidity antibody and effect of route on T cell cytotoxicity
10. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction
11. Antilymphocytic antibodies and marrow transplantation. IX. T-cell depletion in marrow donors with C1q high and low affinity antibodies for suppression of GVHD in fully mismatched mice
12. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells
13. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice
14. Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice
15. Beneficial influence of glycemic control upon the growth and function of transplanted islets
16. Transplantation of the endocrine pancreas in 1992
17. Induction of classical transplantation tolerance in the adult
18. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8
19. Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig
20. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model
21. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3
22. Blockade of multiple costimulatory receptors induces hyporesponsiveness: Inhibition of CD2 plus CD28 pathways
23. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
24. Additive efficacy of CTLA4Ig and OX40Ig secreted by genetically modified grafts